AAV-mediated CYP46A1 delivery is beneficial in Alzheimer's disease models: towards a clinical application

被引：0
|
作者：
Alves, S. [1 ]
Michaelsen-Preusse, K. [2 ]
Audrain, M. [1 ]
Aron-Badin, R. [3 ]
Lamaziere, A. [4 ]
Fol, R. [1 ]
Braudeau, J. [1 ]
Despres, G. [4 ]
Fouquet, F. [1 ]
Pradier, L. [5 ]
Delatour, B. [6 ]
Korte, M. [2 ]
Hantraye, P. [3 ]
Aubourg, P. [1 ]
Cartier, N. [1 ]
机构：
[1] CEA, INSERM, U1169, MIRCen, Fontenay Aux Roses, France
[2] TU Braunschweig, Div Cellular Neurobiol, Inst Zool, Braunschweig, Germany
[3] CEA, DSV, I2BM, MIRCen, F-92265 Fontenay Aux Roses, France
[4] Sorbonne Univ, INSERM, ERL 1157, Pierre & Marie Curie Paris 6, Paris, France
[5] Sanofi, Neurodegenerat & Pain Unit, Chilly Mazarin, France
[6] CNRS, UMR 7225, INSERM, U1127,Inst Cerveau & Moelle Epiniere, Paris, France
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P005
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [1] AAV-mediated CYP46A1 gene therapy for Huntington's disease
    Cartier, N.
    Alves, S.
    Christaller, W.
    Subashi, E.
    Kacher, R.
    Lamaziere, A.
    Despres, G.
    Saudou, F.
    Caboche, J.
    Betuing, S.
    HUMAN GENE THERAPY, 2017, 28 (12) : A3 - A3
  • [2] AAV-Mediated CYP46A1 Gene Therapy as a Strategy to Counteract Huntington's Disease
    Cartier, Nathalie
    Alves, Sandro
    Christaller, Wilhelm
    Subashi, Enedja
    Kacher, Radia
    Lamaziere, Antonin
    Despres, Gaetan
    Piguet, Francoise
    Saudou, Frederic
    Caboche, Jocelyne
    Betuing, Sandrine
    MOLECULAR THERAPY, 2018, 26 (05) : 308 - 309
  • [3] AAV-CYP46A1 is beneficial in Alzheimer's disease: from mice to non-human primates
    Alves, S.
    Michaelsen-Preusse, K.
    Audrain, M.
    Aron-Badin, R.
    Lamaziere, A.
    Rey, E.
    Fol, R.
    Braudeau, J.
    Despres, G.
    Fouquet, F.
    Korte, M.
    Hantraye, P.
    Aubourg, P.
    Cartier, N.
    HUMAN GENE THERAPY, 2017, 28 (12) : A77 - A77
  • [4] CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer’s Disease
    Ling Li
    Fan Zeng
    Yu-Hui Liu
    Hui-Yun Li
    Shu-Yang Dong
    Ze-Yan Peng
    Yan-Jiang Wang
    Hua-Dong Zhou
    Molecular Neurobiology, 2018, 55 : 8179 - 8187
  • [5] CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease
    Li, Ling
    Zeng, Fan
    Liu, Yu-Hui
    Li, Hui-Yun
    Dong, Shu-Yang
    Peng, Ze-Yan
    Wang, Yan-Jiang
    Zhou, Hua-Dong
    MOLECULAR NEUROBIOLOGY, 2018, 55 (10) : 8179 - 8187
  • [6] AAV-Mediated APOE Gene Silencing for Alzheimer's Disease
    Hentschel, Lisa
    Oudshoorn-Dickmann, Maroeska
    Wattimury, Hendrina
    Boggiani, Lorenzo
    Moreno, Fiona
    Tripathi, Shrijana
    Pereira, Ines Lopes
    Nogueira, Ana
    Peris, Sara Gimeno
    Villamil, Javier
    Spronck, Lisa
    Bosma, Bas
    Kusuma, Angga
    Dobrynin, Greg
    Liu, Ying Poi
    MOLECULAR THERAPY, 2022, 30 (04) : 433 - 434
  • [7] CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism
    Koelsch, Heike
    Luetjohann, Dieter
    Jessen, Frank
    Popp, Julius
    Hentschel, Frank
    Kelemen, Peter
    Schmitz, Sandra
    Maier, Wolfgang
    Heun, Reinhard
    EUROPEAN PSYCHIATRY, 2009, 24 (03) : 183 - 190
  • [8] AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model
    Marino, Marika
    Zhou, Lujia
    Rincon, Melvin Y.
    Callaerts-Vegh, Zsuzsanna
    Verhaert, Jens
    Wahis, Jerome
    Creemers, Eline
    Yshii, Lidia
    Wierda, Keimpe
    Saito, Takashi
    Marneffe, Catherine
    Voytyuk, Iryna
    Wouters, Yessica
    Dewilde, Maarten
    Duque, Sandra, I
    Vincke, Cecile
    Levites, Yona
    Golde, Todd E.
    Saido, Takaomi C.
    Muyldermans, Serge
    Liston, Adrian
    De Strooper, Bart
    Holt, Matthew G.
    EMBO MOLECULAR MEDICINE, 2022, 14 (04)
  • [9] CYP46A1 Functional Promoter Haplotypes Decipher Genetic Susceptibility to Alzheimer's Disease
    Li, Yan
    Chu, Leung-Wing
    Wang, Binbin
    Yik, Ping-Yiu
    Huriletemuer
    Jin, Dong-Yan
    Ma, Xu
    Song, You-Qiang
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (04) : 1311 - 1323
  • [10] LincRNA Plays a Role in the Effect of CYP46A1 Polymorphism in Alzheimer's Disease - Related Pathology
    Chen, Yang
    Li, Hui-Yun
    Zeng, Fan
    Chen, Le
    Zhou, Fa-Ying
    Peng, Ze-Yan
    Yang, Hai
    Zhou, Hua-Dong
    Wang, Yan-Jiang
    Li, Ling
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 11
12345